SEC filing · 8-K

InspireMD, Inc.: Material agreement

InspireMD amended terms for certain Series J and Series K warrants to reduce the exercise price and align expiration with expected FDA approval.

Filed September 21, 2026

Positive for the company

What happened

On September 21, 2026, InspireMD entered into warrant amendments with certain existing holders of its Series J and Series K warrants.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to InspireMD, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.